Research using biomarkers that were carried out in EOAD and late onset of AD (LOAD) has revealed a chronological sequence between the early stages of Aβ pathology, the development of Aβ aggregation species and plaques across the brain, and ultimately tau and natural signatures associated with neurodegeneration. This evidence concerns the gene MAPT and Alzheimer disease.